![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 30, 19130-19139, July 24, 1998
From the Department of Pharmacology and Vincent T. Lombardi Cancer
Center, Georgetown University, Washington, D. C. 20007
Earlier studies from our laboratory showed that
a secreted binding protein for fibroblast growth factors (FGF-BP) is
expressed at high levels in squamous cell carcinoma (SCC) cell lines.
Overexpression studies or conversely reduced expression of FGF-BP by
ribozyme targeting have elucidated a direct role of this protein in
angiogenesis during tumor development. We have also observed a
significant up-regulation of FGF-BP during TPA
(12-O-tetradecanoylphorbol-13-acetate) promotion of skin
cancer. Here we investigate the mechanism of TPA induction of FGF-BP
gene expression in the human ME-180 SCC cell line. We found that TPA
increased FGF-BP mRNA levels in a time- and
dose-dependent manner mediated via the protein kinase C
signal transduction pathway. Results from actinomycin D and cycloheximide experiments as well as nuclear transcription assays revealed that TPA up-regulated the steady-state levels of FGF-BP mRNA by increasing its rate of gene transcription independently of
de novo protein synthesis. We isolated the human FGF-BP
promoter and determined by deletion analysis that TPA regulatory
elements were all contained in the first 118 base pairs upstream of the transcription start site. Further mutational analysis revealed that
full TPA induction required interplay between several regulatory elements with homology to Ets, AP-1, and CAATT/enhancer binding protein
C/EBP sites. In addition, deletion or mutation of a 10-base pair region
juxtaposed to the AP-1 site dramatically increased TPA induced FGF-BP
gene expression. This region represses the extent of the FGF-BP
promoter response to TPA and contained sequences recognized by the
family of E box helix-loop-helix transcription factors. Gel shift
analysis showed specific and TPA-inducible protein binding to the Ets,
AP-1, and C/EBP sites. Furthermore, distinct, specific, and
TPA-inducible binding to the imperfect E box repressor element was also
apparent. Overall, our data indicate that TPA effects on FGF-BP gene
transcription are tightly controlled by a complex interplay of positive
elements and a novel negative regulatory element.
Phorbol Ester-induced Transcription of a Fibroblast Growth
Factor-binding Protein Is Modulated by a Complex Interplay of
Positive and Negative Regulatory Promoter Elements
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-J. Im, P. Muddasani, V. Natarajan, T. M. Schmid, J. A. Block, F. Davis, A. J. van Wijnen, and R. F. Loeser Basic Fibroblast Growth Factor Stimulates Matrix Metalloproteinase-13 via the Molecular Cross-talk between the Mitogen-activated Protein Kinases and Protein Kinase C{delta} Pathways in Human Adult Articular Chondrocytes J. Biol. Chem., April 13, 2007; 282(15): 11110 - 11121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xie, E. Tassi, M. R. Swift, K. McDonnell, E. T. Bowden, S. Wang, Y. Ueda, Y. Tomita, A. T. Riegel, and A. Wellstein Identification of the Fibroblast Growth Factor (FGF)-interacting Domain in a Secreted FGF-binding Protein by Phage Display J. Biol. Chem., January 13, 2006; 281(2): 1137 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ray, R. Cabal-Manzano, A. R. Moser, T. Waldman, L. M. Zipper, A. Aigner, S. W. Byers, A. T. Riegel, and A. Wellstein Up-Regulation of Fibroblast Growth Factor-Binding Protein, by {beta}-Catenin during Colon Carcinogenesis Cancer Res., December 1, 2003; 63(23): 8085 - 8089. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Kagan, R. T. Henke, R. Cabal-Manzano, G. E. Stoica, Q. Nguyen, A. Wellstein, and A. T. Riegel Complex Regulation of the Fibroblast Growth Factor-binding Protein in MDA- MB-468 Breast Cancer Cells by CCAAT/Enhancer-binding Protein {beta} Cancer Res., April 1, 2003; 63(7): 1696 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xing, N. Danilovich, and M. R. Sairam Orphan Receptor Chicken Ovalbumin Upstream Promoter Transcription Factors Inhibit Steroid Factor-1, Upstream Stimulatory Factor, and Activator Protein-1 Activation of Ovine Follicle-Stimulating Hormone Receptor Expression via Composite cis-Elements Biol Reprod, June 1, 2002; 66(6): 1656 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tassi, A. Al-Attar, A. Aigner, M. R. Swift, K. McDonnell, A. Karavanov, and A. Wellstein Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein J. Biol. Chem., October 19, 2001; 276(43): 40247 - 40253. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Harris, C. M. Coticchia, B. L. Kagan, S. Ahmad, A. Wellstein, and A. T. Riegel Induction of the Angiogenic Modulator Fibroblast Growth Factor-binding Protein by Epidermal Growth Factor Is Mediated through Both MEK/ERK and p38 Signal Transduction Pathways J. Biol. Chem., April 6, 2000; 275(15): 10802 - 10811. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schneider, M. Martin, F. A. Agarraberes, L. Yin, I. Rapoport, T. Kirchhausen, and C. E. Rudd Cytolytic T Lymphocyte-Associated Antigen-4 and the TCR{zeta}/CD3 Complex, But Not CD28, Interact with Clathrin Adaptor Complexes AP-1 and AP-2 J. Immunol., August 15, 1999; 163(4): 1868 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Harris, C. M. Coticchia, H.-J. List, A. Wellstein, and A. T. Riegel Mitogen-induced Expression of the Fibroblast Growth Factor-binding Protein Is Transcriptionally Repressed through a Non-canonical E-box Element J. Biol. Chem., September 8, 2000; 275(37): 28539 - 28548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lametsch, J. T. Rasmussen, L. B. Johnsen, S. Purup, K. Sejrsen, T. E. Petersen, and C. W. Heegaard Structural Characterization of the Fibroblast Growth Factor-binding Protein Purified from Bovine Prepartum Mammary Gland Secretion J. Biol. Chem., June 23, 2000; 275(26): 19469 - 19474. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. List, K. J. Lauritsen, R. Reiter, C. Powers, A. Wellstein, and A. T. Riegel Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells J. Biol. Chem., June 22, 2001; 276(26): 23763 - 23768. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |